News | Cardiovascular Business | May 11, 2022

Vital Heart & Vein Names Gay Nord, MHA as New CEO

Gay Nord

Gay Nord


May 11, 2022 — Vital Heart & Vein, a leading provider of cardiovascular and vein health, has named Gay Nord as its new chief executive officer. 

In her new role, she will oversee operations of Vital Heart & Vein's current and future locations and spearhead the organization's growth and development. 

Nord most recently served as CEO for Hospital Corporation of America (HCA) Florida West Hospital for several years. Prior to HCA Florida West, she served in the same capacity at St. Luke's Medical Center in Houston and HCA's Methodist Hospital and Methodist Children's Hospital in San Antonio. 

Additionally, Nord has served in key leadership positions at HCA's Overland Park Regional Medical Center in Overland Park, Kansas, and HCA's Kingwood Medical Center in Houston. 

With extensive experience in creating physician partnerships, service line development, and cardiovascular services, Nord has established a track record for leading organizations to unprecedented growth and expansion. 

"Without question, Nord is the ideal choice to lead Vital Heart & Vein to the next level. Her bold and transparent leadership, coupled with her strategic mindset and an excellent record of success, will continue to propel the organization forward into the future," said Mazen Ganim, M.D., founding partner of Vital Heart & Vein.

"I am honored to lead an organization like Vital Heart & Vein known for its commitment to providing high quality and compassionate care to its patients," said Nord. "Over the last 24 years, Vital Heart & Vein has established itself as a leading cardiovascular and vein treatment provider. I look forward to working with the phenomenal physicians and employees at Vital Heart & Vein and playing a role in its future growth and success. I consider it a privilege to join an organization dedicated to providing exceptional care to their patients."

A member of the American College of Healthcare executives, Nord received her Bachelor of Business Administration from the University of Houston and her Master of Science in Healthcare Administration from Texas Woman's University. 

For more information: https://vitalheartandvein.com


Related Content

News | Cardiovascular Business

July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing ...

Home July 29, 2024
Home
News | Cardiovascular Business

July 18, 2024 — Circle Cardiovascular Imaging, a developer of artificial intelligence (AI)-driven cardiovascular imaging ...

Home July 18, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Guidehealth, an artificial intelligence (AI)-enabled healthcare services company, has announced a ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...

Home July 11, 2024
Home
News | Cardiovascular Business

July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...

Home July 09, 2024
Home
Feature | Cardiovascular Business

The DAIC team wishes you a safe and happy 4th of July!

Home July 04, 2024
Home
News | Cardiovascular Business

July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...

Home July 03, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June: 1 ...

Home July 02, 2024
Home
News | Cardiovascular Business

July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...

Home July 01, 2024
Home
Subscribe Now